Overestimation of free light chain antigen excess rate

被引:7
作者
Vercammen, Martine J. [1 ,2 ]
Broodtaerts, Linda [1 ]
Meirlaen, Patricia [1 ]
Bossuyt, Xavier [3 ,4 ]
机构
[1] Univ Ziekenhuis Brussel UZ Brussel, Dept Hematol, B-1090 Brussels, Belgium
[2] Vrije Univ Brussel, Res Grp Reprod Immunol & Implantat REIM, B-1090 Brussels, Belgium
[3] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Microbiol & Immunol, Lab Med, B-3000 Louvain, Belgium
[4] Katholieke Univ Leuven, Expt Immunol Lab, B-3000 Louvain, Belgium
关键词
Immunoglobulin; Free light chain; Monoclonal gammopathy; Hook effect; Antigen excess; MONOCLONAL GAMMOPATHY; UNDETERMINED SIGNIFICANCE; PROGRESSION;
D O I
10.1016/j.cca.2015.02.047
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Free light chains (FLC) are useful biomarkers for diagnosis and follow-up of plasma cell disorders. PLC quantification is encumbered by non-linearity and antigen excess (>4-fold difference between results obtained at the 2000- and 100-fold dilution). Methods: PLC concentration was measured with Freelite (R) reagents on the BNII, using 100- and 2000-fold dilutions in 3645 samples. Samples displaying antigen excess were re-measured at the 2000- and/or 400-fold dilution. Carryover was evaluated by tracing samples to cuvettes and by measuring a normal sample in cuvettes that previously contained samples with a high PLC concentration. Results: Antigen excess occurred in 0.93% of samples for kappa and in 0.55% of samples for lambda. In 81.5% of the cases, it could not be confirmed by a re-analysis of a 2000-fold and/or a 400-fold diluted sample. Real antigen excess was documented in 0.25% and 0.03% of the samples for kappa and lambda PLC, respectively. In the low concentration range (2000-fold dilution), imprecision was high. False antigen excess was reduced by batch analysis, introducing cleaning and rinsing procedures and using the 400-fold dilution. No antigen excess was detected in samples with normal PLC concentrations. Conclusion: Falsely high results occur by imprecision in the low concentration range and/or by carryover in cuvettes. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:297 / 302
页数:6
相关论文
共 13 条
[1]   Detection of serum free light chains: the problem with antigen excess [J].
Bosmann, Markus ;
Koessler, Juergen ;
Stolz, Herbert ;
Walter, Ulrich ;
Knop, Stefan ;
Steigerwald, Udo .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (10) :1419-1422
[2]   Monoclonal gammopathy related to Sjogren syndrome: A key marker of disease prognosis and outcomes [J].
Brito-Zeron, Pilar ;
Retamozo, Soledad ;
Gandia, Myriam ;
Akasbi, Miriam ;
Perez-De-Lis, Marta ;
Diaz-Lagares, Candido ;
Bosch, Xavier ;
Bove, Albert ;
Perez-Alvarez, Roberto ;
Soto-Cardenas, Maria-Jose ;
Siso, Antoni ;
Ramos-Casals, Manuel .
JOURNAL OF AUTOIMMUNITY, 2012, 39 (1-2) :43-48
[3]   Normalization of serum-free light chains in patients with systemic lupus erythematosus upon rituximab treatment and correlation with biological disease activity [J].
Chiche, L. ;
Cournac, J. M. ;
Mancini, J. ;
Bardin, N. ;
Thomas, G. ;
Jean, R. ;
Schleinitz, N. ;
Kaplanski, G. ;
Durand, J. M. ;
Boucraut, J. ;
Harle, J. R. .
CLINICAL RHEUMATOLOGY, 2011, 30 (05) :685-689
[4]   International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders [J].
Dispenzieri, A. ;
Kyle, R. ;
Merlini, G. ;
Miguel, J. S. ;
Ludwig, H. ;
Hajek, R. ;
Palumbo, A. ;
Jagannath, S. ;
Blade, J. ;
Lonial, S. ;
Dimopoulos, M. ;
Comenzo, R. ;
Einsele, H. ;
Barlogie, B. ;
Anderson, K. ;
Gertz, M. ;
Harousseau, J. L. ;
Attal, M. ;
Tosi, P. ;
Sonneveld, P. ;
Boccadoro, M. ;
Morgan, G. ;
Richardson, P. ;
Sezer, O. ;
Mateos, M. V. ;
Cavo, M. ;
Joshua, D. ;
Turesson, I. ;
Chen, W. ;
Shimizu, K. ;
Powles, R. ;
Rajkumar, S. V. ;
Durie, B. G. M. .
LEUKEMIA, 2009, 23 (02) :215-224
[5]   Serum free light chain immunoassays: A guide to antigen excess detection [J].
Jenner, Ellen ;
Levoguer, Alison ;
Evans, Josie ;
Harding, Stephen .
CLINICA CHIMICA ACTA, 2012, 413 (9-10) :949-949
[6]   Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus [J].
Jolly, M. ;
Francis, S. ;
Aggarwal, R. ;
Mikolaitis, R. A. ;
Niewold, T. B. ;
Chubinskaya, S. ;
Block, J. A. ;
Scanzello, C. ;
Sequeira, W. .
LUPUS, 2014, 23 (09) :881-888
[7]   Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management [J].
Kyle, R. A. ;
Durie, B. G. M. ;
Rajkumar, S. V. ;
Landgren, O. ;
Blade, J. ;
Merlini, G. ;
Kroeger, N. ;
Einsele, H. ;
Vesole, D. H. ;
Dimopoulos, M. ;
San Miguel, J. ;
Avet-Loiseau, H. ;
Hajek, R. ;
Chen, W. M. ;
Anderson, K. C. ;
Ludwig, H. ;
Sonneveld, P. ;
Pavlovsky, S. ;
Palumbo, A. ;
Richardson, P. G. ;
Barlogie, B. ;
Greipp, P. ;
Vescio, R. ;
Turesson, I. ;
Westin, J. ;
Boccadoro, M. .
LEUKEMIA, 2010, 24 (06) :1121-1127
[8]   Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma [J].
Kyle, Robert A. ;
San-Miguel, Jesus F. ;
Mateos, Maria-Victoria ;
Rajkumar, S. Vincent .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (05) :775-+
[9]   A multicentre study comparing two methods for serum free light chain analysis [J].
Lock, R. J. ;
Saleem, R. ;
Roberts, E. G. ;
Wallage, M. J. ;
Pesce, T. J. ;
Rowbottom, A. ;
Cooper, S. J. ;
McEvoy, E. D. ;
Taylor, J. L. ;
Basu, S. .
ANNALS OF CLINICAL BIOCHEMISTRY, 2013, 50 (03) :255-261
[10]  
Mumg SH, 2013, CLIN EXP IMMUNOL, V171, P201